2022
Exports
$31MWorld Rnk 56 / 208
Flag Rnk 214 / 1199
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$1.17BWorld Rnk 33 / 225
Flag Rnk 10 / 1208
2022
ECONOMIC COMPLEXITY of Greece
0.33Rnk 50 / 133

About

Exports In 2022, Greece exported $31M in Vaccines, blood, antisera, toxins and cultures, making it the 56th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 214th most exported product in Greece. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Greece are: Cyprus ($11.8M), Germany ($9.56M), Netherlands ($2.91M), Gabon ($1.4M), and Malta ($1.14M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Greece between 2021 and 2022 were Germany ($5.7M), Netherlands ($2.71M), and Gabon ($1.4M).

Imports In 2022, Greece imported $1.17B in Vaccines, blood, antisera, toxins and cultures, becoming the 33rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 10th most imported product in Greece. Greece imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($405M), Belgium ($235M), Netherlands ($182M), Switzerland ($152M), and France ($60.4M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Greece between 2021 and 2022 were Belgium ($35.8M), Netherlands ($21.6M), and Switzerland ($8.79M).

Latest Trends

Jul 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$31M
IMPORTS (2022)$1.17B
NET TRADE (2022)-$1.14B

In 2022, Greece exported $31M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Greece exports on Vaccines, blood, antisera, toxins and cultures were Cyprus ($11.8M), Germany ($9.56M), Netherlands ($2.91M), Gabon ($1.4M), and Malta ($1.14M).

In 2022, Greece imported $1.17B in Vaccines, blood, antisera, toxins and cultures, mainly from Germany ($405M), Belgium ($235M), Netherlands ($182M), Switzerland ($152M), and France ($60.4M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Greece WERE (2021 - 2022):
Germany$5.7M (147%)
Netherlands$2.71M (1.34k%)
Gabon$1.4M (1%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Greece WERE (2021 - 2022):
Cyprus-$14.6M (-55.2%)
Egypt-$1.74M (-99.4%)
Malta-$1.2M (-51.2%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Greece's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Greece's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALGermany+ $7.86M
TOP IMPORT POTENTIALSwitzerland+ $41.9M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Germany. With an export gap of $7.86M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Switzerland with an import gap of $41.9M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with